Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | M552_V559del |
Impact List | deletion |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | KIT M552_V559del results in the deletion of eight amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 552 to 559 (PMID: 16226710). M552_V559del results in constitutive Kit phosphorylation in cell culture (PMID: 20633291), and therefore, is predicted to lead to a gain of Kit protein function. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT exon 11 del KIT M552_V559del KIT mutant KIT exon11 KIT exon 11 del KIT M552_V559del |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727422_54727445del24 |
cDNA | c.1654_1677del24 |
Protein | p.M552_V559delMYEVQWKV |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001385292.1 | chr4:g.54727431_54727454del24 | c.1654_1677del24 | p.V552_E559delVQWKVVEE | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54727422_54727445del24 | c.1654_1677del24 | p.M552_V559delMYEVQWKV | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54727434_54727457del24 | c.1654_1677del24 | p.Q552_I559delQWKVVEEI | RefSeq | GRCh38/hg38 |
NM_001385288.1 | chr4:g.54727431_54727454del24 | c.1654_1677del24 | p.V552_E559delVQWKVVEE | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54727422_54727445del24 | c.1654_1677del24 | p.M552_V559delMYEVQWKV | RefSeq | GRCh38/hg38 |
XM_017008180.1 | chr4:g.54727434_54727457del24 | c.1654_1677del24 | p.Q552_I559delQWKVVEEI | RefSeq | GRCh38/hg38 |
XM_005265740 | chr4:g.54727419_54727442del24 | c.1654_1677del24 | p.P552_K559delPMYEVQWK | RefSeq | GRCh38/hg38 |
NM_001093772 | chr4:g.54727434_54727457del24 | c.1654_1677del24 | p.Q552_I559delQWKVVEEI | RefSeq | GRCh38/hg38 |
NM_001385284.1 | chr4:g.54727419_54727442del24 | c.1654_1677del24 | p.P552_K559delPMYEVQWK | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54727422_54727445del24 | c.1654_1677del24 | p.M552_V559delMYEVQWKV | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54727422_54727445del24 | c.1654_1677del24 | p.M552_V559delMYEVQWKV | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727422_54727445del24 | c.1654_1677del24 | p.M552_V559delMYEVQWKV | RefSeq | GRCh38/hg38 |
XM_005265742 | chr4:g.54727431_54727454del24 | c.1654_1677del24 | p.V552_E559delVQWKVVEE | RefSeq | GRCh38/hg38 |
XM_005265741.1 | chr4:g.54727419_54727442del24 | c.1654_1677del24 | p.P552_K559delPMYEVQWK | RefSeq | GRCh38/hg38 |
XM_005265742.3 | chr4:g.54727431_54727454del24 | c.1654_1677del24 | p.V552_E559delVQWKVVEE | RefSeq | GRCh38/hg38 |
XM_017008180 | chr4:g.54727434_54727457del24 | c.1654_1677del24 | p.Q552_I559delQWKVVEEI | RefSeq | GRCh38/hg38 |
XM_017008179 | chr4:g.54727431_54727454del24 | c.1654_1677del24 | p.V552_E559delVQWKVVEE | RefSeq | GRCh38/hg38 |
NM_001093772.1 | chr4:g.54727434_54727457del24 | c.1654_1677del24 | p.Q552_I559delQWKVVEEI | RefSeq | GRCh38/hg38 |
NM_001385290.1 | chr4:g.54727419_54727442del24 | c.1654_1677del24 | p.P552_K559delPMYEVQWK | RefSeq | GRCh38/hg38 |
XM_005265740.1 | chr4:g.54727419_54727442del24 | c.1654_1677del24 | p.P552_K559delPMYEVQWK | RefSeq | GRCh38/hg38 |
XM_005265741 | chr4:g.54727419_54727442del24 | c.1654_1677del24 | p.P552_K559delPMYEVQWK | RefSeq | GRCh38/hg38 |
XM_017008179.1 | chr4:g.54727431_54727454del24 | c.1654_1677del24 | p.V552_E559delVQWKVVEE | RefSeq | GRCh38/hg38 |
NM_001385286.1 | chr4:g.54727434_54727457del24 | c.1654_1677del24 | p.Q552_I559delQWKVVEEI | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54727422_54727445del24 | c.1654_1677del24 | p.M552_V559delMYEVQWKV | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT M552_V559del | Advanced Solid Tumor | sensitive | Motesanib Diphosphate | Preclinical - Cell culture | Actionable | In a preclinical study, Motesanib (AMG 706) inhibited KIT phosphorylation and growth of cells expressing KIT M552_V559del in culture (PMID: 20633291). | 20633291 |